Jan Chen, PhD, serves as a Senior R&D Manager at Boston Scientific, overseeing the development and integration of the WATCHMAN therapy system since 2020. Prior experience includes roles as a Principal R&D Engineer and Tech Lead at Boston Scientific, where Jan led a cross-functional team in developing a next-generation LAAC therapy and managed product portfolios to meet clinical needs. During tenure at Baylis Medical Company, Jan managed multiple R&D teams, successfully bringing new medical devices to market across various countries while fostering a high-performance team culture. Academic credentials include a postdoctoral fellowship at Harvard Medical School focused on biomedical engineering and a Ph.D. from the University of Toronto, where Jan conducted significant research in mechanical and biomedical engineering, contributing to innovations in cardiovascular medical devices.